Marketing to a segment of one

Prescribing events - such as a physician swapping one brand for another when titration might have kept the patient on the initial product, or prescribing a therapy as an add-on to an existing therapy when it should be the initiating monotherapy - can make or break a brand's success. Informing b...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Pharmaceutical Executive 2003-03, Vol.23 (3), p.110
1. Verfasser: Barnes, Michael L
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue 3
container_start_page 110
container_title Pharmaceutical Executive
container_volume 23
creator Barnes, Michael L
description Prescribing events - such as a physician swapping one brand for another when titration might have kept the patient on the initial product, or prescribing a therapy as an add-on to an existing therapy when it should be the initiating monotherapy - can make or break a brand's success. Informing brand managers how often such events occur, where they occur, and how best to respond to them describes the paradigm shift currently underway in pharma marketing. That information provides valuable insight into how physicians are prescribing products, enabling marketing strategies that can take advantage of those behavior patterns.
format Article
fullrecord <record><control><sourceid>proquest</sourceid><recordid>TN_cdi_proquest_reports_216422941</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>318608491</sourcerecordid><originalsourceid>FETCH-proquest_reports_2164229413</originalsourceid><addsrcrecordid>eNpjYuA0MjQ10DU3No1gYeA0MDK31DUzNTfgYOAqLs4yMDAwMTG14GSQ9U0syk4tycxLVyjJV0hUKE5Nz03NK1HIT1PIz0vlYWBNS8wpTuWF0twMim6uIc4eugVF-YWlqcUl8UWpBflFJcXxRoZmJkZGliaGxsSoAQBTXSu2</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>216422941</pqid></control><display><type>article</type><title>Marketing to a segment of one</title><source>Business Source Complete</source><creator>Barnes, Michael L</creator><creatorcontrib>Barnes, Michael L</creatorcontrib><description>Prescribing events - such as a physician swapping one brand for another when titration might have kept the patient on the initial product, or prescribing a therapy as an add-on to an existing therapy when it should be the initiating monotherapy - can make or break a brand's success. Informing brand managers how often such events occur, where they occur, and how best to respond to them describes the paradigm shift currently underway in pharma marketing. That information provides valuable insight into how physicians are prescribing products, enabling marketing strategies that can take advantage of those behavior patterns.</description><identifier>ISSN: 0279-6570</identifier><identifier>EISSN: 2150-735X</identifier><language>eng</language><publisher>Monmouth Junction: MultiMedia Healthcare Inc</publisher><subject>Behavior ; Beta blockers ; Diuretics ; Market segments ; Market strategy ; Marketing ; Patients ; Physicians ; Prescription drugs</subject><ispartof>Pharmaceutical Executive, 2003-03, Vol.23 (3), p.110</ispartof><rights>Copyright Advanstar Communications, Inc. Mar 2003</rights><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>313,782,786,793</link.rule.ids></links><search><creatorcontrib>Barnes, Michael L</creatorcontrib><title>Marketing to a segment of one</title><title>Pharmaceutical Executive</title><description>Prescribing events - such as a physician swapping one brand for another when titration might have kept the patient on the initial product, or prescribing a therapy as an add-on to an existing therapy when it should be the initiating monotherapy - can make or break a brand's success. Informing brand managers how often such events occur, where they occur, and how best to respond to them describes the paradigm shift currently underway in pharma marketing. That information provides valuable insight into how physicians are prescribing products, enabling marketing strategies that can take advantage of those behavior patterns.</description><subject>Behavior</subject><subject>Beta blockers</subject><subject>Diuretics</subject><subject>Market segments</subject><subject>Market strategy</subject><subject>Marketing</subject><subject>Patients</subject><subject>Physicians</subject><subject>Prescription drugs</subject><issn>0279-6570</issn><issn>2150-735X</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2003</creationdate><recordtype>article</recordtype><sourceid>8G5</sourceid><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>AZQEC</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><sourceid>DWQXO</sourceid><sourceid>GNUQQ</sourceid><sourceid>GUQSH</sourceid><sourceid>M2O</sourceid><recordid>eNpjYuA0MjQ10DU3No1gYeA0MDK31DUzNTfgYOAqLs4yMDAwMTG14GSQ9U0syk4tycxLVyjJV0hUKE5Nz03NK1HIT1PIz0vlYWBNS8wpTuWF0twMim6uIc4eugVF-YWlqcUl8UWpBflFJcXxRoZmJkZGliaGxsSoAQBTXSu2</recordid><startdate>20030301</startdate><enddate>20030301</enddate><creator>Barnes, Michael L</creator><general>MultiMedia Healthcare Inc</general><scope>0U~</scope><scope>1-H</scope><scope>3V.</scope><scope>7RV</scope><scope>7WY</scope><scope>7WZ</scope><scope>7X7</scope><scope>7XB</scope><scope>87Z</scope><scope>883</scope><scope>88C</scope><scope>8AO</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>8FL</scope><scope>8G5</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>BEZIV</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FRNLG</scope><scope>FYUFA</scope><scope>F~G</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>GUQSH</scope><scope>K60</scope><scope>K6~</scope><scope>K9.</scope><scope>KB0</scope><scope>L.-</scope><scope>L.0</scope><scope>M0C</scope><scope>M0F</scope><scope>M0S</scope><scope>M0T</scope><scope>M2O</scope><scope>MBDVC</scope><scope>NAPCQ</scope><scope>PQBIZ</scope><scope>PQBZA</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>Q9U</scope><scope>S0X</scope></search><sort><creationdate>20030301</creationdate><title>Marketing to a segment of one</title><author>Barnes, Michael L</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-proquest_reports_2164229413</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2003</creationdate><topic>Behavior</topic><topic>Beta blockers</topic><topic>Diuretics</topic><topic>Market segments</topic><topic>Market strategy</topic><topic>Marketing</topic><topic>Patients</topic><topic>Physicians</topic><topic>Prescription drugs</topic><toplevel>online_resources</toplevel><creatorcontrib>Barnes, Michael L</creatorcontrib><collection>Global News &amp; ABI/Inform Professional</collection><collection>Trade PRO</collection><collection>ProQuest Central (Corporate)</collection><collection>Nursing &amp; Allied Health Database</collection><collection>Access via ABI/INFORM (ProQuest)</collection><collection>ABI/INFORM Global (PDF only)</collection><collection>Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>ABI/INFORM Global (Alumni Edition)</collection><collection>ABI/INFORM Trade &amp; Industry (Alumni Edition)</collection><collection>Healthcare Administration Database (Alumni)</collection><collection>ProQuest Pharma Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ABI/INFORM Collection (Alumni Edition)</collection><collection>Research Library (Alumni Edition)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central Essentials</collection><collection>ProQuest Central</collection><collection>Business Premium Collection</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Business Premium Collection (Alumni)</collection><collection>Health Research Premium Collection</collection><collection>ABI/INFORM Global (Corporate)</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>Research Library Prep</collection><collection>ProQuest Business Collection (Alumni Edition)</collection><collection>ProQuest Business Collection</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Nursing &amp; Allied Health Database (Alumni Edition)</collection><collection>ABI/INFORM Professional Advanced</collection><collection>ABI/INFORM Professional Standard</collection><collection>ABI/INFORM Global</collection><collection>ABI/INFORM Trade &amp; Industry</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>Healthcare Administration Database</collection><collection>Research Library</collection><collection>Research Library (Corporate)</collection><collection>Nursing &amp; Allied Health Premium</collection><collection>ProQuest One Business</collection><collection>ProQuest One Business (Alumni)</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central Basic</collection><collection>SIRS Editorial</collection><jtitle>Pharmaceutical Executive</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Barnes, Michael L</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Marketing to a segment of one</atitle><jtitle>Pharmaceutical Executive</jtitle><date>2003-03-01</date><risdate>2003</risdate><volume>23</volume><issue>3</issue><spage>110</spage><pages>110-</pages><issn>0279-6570</issn><eissn>2150-735X</eissn><abstract>Prescribing events - such as a physician swapping one brand for another when titration might have kept the patient on the initial product, or prescribing a therapy as an add-on to an existing therapy when it should be the initiating monotherapy - can make or break a brand's success. Informing brand managers how often such events occur, where they occur, and how best to respond to them describes the paradigm shift currently underway in pharma marketing. That information provides valuable insight into how physicians are prescribing products, enabling marketing strategies that can take advantage of those behavior patterns.</abstract><cop>Monmouth Junction</cop><pub>MultiMedia Healthcare Inc</pub></addata></record>
fulltext fulltext
identifier ISSN: 0279-6570
ispartof Pharmaceutical Executive, 2003-03, Vol.23 (3), p.110
issn 0279-6570
2150-735X
language eng
recordid cdi_proquest_reports_216422941
source Business Source Complete
subjects Behavior
Beta blockers
Diuretics
Market segments
Market strategy
Marketing
Patients
Physicians
Prescription drugs
title Marketing to a segment of one
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-02T20%3A52%3A33IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Marketing%20to%20a%20segment%20of%20one&rft.jtitle=Pharmaceutical%20Executive&rft.au=Barnes,%20Michael%20L&rft.date=2003-03-01&rft.volume=23&rft.issue=3&rft.spage=110&rft.pages=110-&rft.issn=0279-6570&rft.eissn=2150-735X&rft_id=info:doi/&rft_dat=%3Cproquest%3E318608491%3C/proquest%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=216422941&rft_id=info:pmid/&rfr_iscdi=true